Skip to main navigation Skip to search Skip to main content

Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

  • PEARL-1 and PEARL-2 trial investigators

Research output: Contribution to journal › Article › peer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology

Neuroscience